Posts by Casey Frazier
Innovation Grand Rounds: Investing in your Home-Grown Innovations
Innovation Grand Rounds is a monthly live series with talks by innovators and executives from across the Mass General Brigham system. Meredith Fisher, PhD, Partner at Mass General Brigham Ventures, recently spoke about strategies for advancing bench-to-bedside innovation to the market. On July 20, 2022, Meredith Fisher, PhD, Partner at Mass General Brigham Ventures,…
Read MoreFour Brigham Ignite Awards Announced
Innovations focus on CT-guided neurosurgery, knee osteoarthritis, brain tumors, and C-sections BOSTON, MA – September 7, 2022 Four Brigham Ignite awards were announced today, bringing the total number of awards given to Brigham and Women’s Hospital innovators, so far this year, to 10. The awards are granted for early-stage innovation acceleration projects that advance…
Read MoreArtificial Intelligence Model Outperforms Clinicians in Diagnosing Pediatric Ear Infections
In collaboration with Mass General Brigham Innovation, OtoDx is currently being employed in a prototype device paired with a smartphone app. As feedback for the pilot is processed, Mass General Brigham Innovation will support the OtoDx team in exploring opportunities to commercialize this impactful tool to assist even more clinicians and their patients. BOSTON,…
Read MoreFirst Brigham Ignite Awards Announced
Brigham Ignite, Brigham and Women’s early-stage innovation acceleration program that advances discoveries with clinical and commercial potential, recently announced the first six recipients of its Brigham Ignite Awards. Along with supportive funding, the awards provide recipients with guidance on licensing, product development, intellectual property and commercialization so that principal investigators are able to take the…
Read MoreThe Medically Engineered Solutions in Healthcare (MESH) Incubator: A case study of innovation “push”
In an opinion piece for STAT, Marc Succi, MD, Clinician-in-Residence at Mass General Brigham Innovation, addresses the importance of innovation education and support for all health care professionals. Read more about the Medically Engineered Solutions in Healthcare (MESH) Incubator established at Mass General Brigham in 2016, and how we are working to change the landscape…
Read More2022 World Medical Innovation Forum | Day 3 Recap
The final day of the World Medical Innovation Forum began with a discussion on the fast-moving landscape of cell therapies for cancer. The Cell Therapy Landscape | CAR-T to Stem Cells Christina Coughlin, MD, PhD, CEO of CytoImmune, detailed three biological principles her team is factoring into their approach to developing T cell and…
Read More2022 World Medical Innovation Forum | Day 2 Recap
Day 2 of World Medical Innovation Forum kicked off with a fireside chat with FDA commissioner Robert Califf, MD. Califf, who recently began his second tour as commissioner, was asked about accelerated approval for new drugs with unvalidated biomarkers based on the opinion it is “reasonably likely” a change in these biomarkers predicts a…
Read More2022 World Medical Innovation Forum | Day 1 Recap
The 2022 World Medical Innovation Forum returned as an in-person event with a partnership between Mass General Brigham and Bank of America. Now in its eighth year, the Forum provides an unprecedented three-day immersion into the world of gene and cell therapies (GCT) and the investment opportunities emerging from this astonishing field. First Look Sessions…
Read MoreTop 12 Emerging Gene and Cell Therapy Technologies Likely to Impact Patient Care Announced in Annual “Disruptive Dozen” from Mass General Brigham
Breakthroughs range from restoration of sight and increasing the supply of donor organs, to treating brain cancer, hearing loss, and autoimmune diseases BOSTON, MA – May 4, 2022 — Mass General Brigham today revealed the annual “Disruptive Dozen,” 12 emerging gene and cell therapy (GCT) technologies with the greatest potential to impact health care in…
Read MoreMass General Brigham Awards $1 Million to Biotech Breakthroughs
Game-changing biotech innovations include new delivery system for brain cancer therapeutics, better detection of potential pregnancy complications, single-handed central line placement device, and more. BOSTON, MA – May 3, 2022 Ten biotech advancements from Mass General Brigham have been awarded Innovation Discovery Grants (IDG) in the 2022 round of awards for the highly competitive grant…
Read More